Advertisement

Topics

Cantargia - Full Phase I data presented at ASCO

08:58 EDT 13 Jun 2019 | FinanzNachrichten

Cantargia presented full data (n=22) from the Phase I part of the CANFOUR study at ASCO on 2 June 2019. These data (safety, biomarker and early efficacy data) were consistent with the interim data ...

Original Article: Cantargia - Full Phase I data presented at ASCO

NEXT ARTICLE

More From BioPortfolio on "Cantargia - Full Phase I data presented at ASCO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...